BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25421847)

  • 1. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
    Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
    BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
    Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
    J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLH1-93G > A is a risk factor for MSI colorectal cancer.
    Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
    Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic DNA methylation landscape of the
    Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
    Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
    Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
    J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
    Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
    PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
    BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
    Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.
    Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M
    Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
    Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
    PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.
    Perera S; Mrkonjic M; Rawson JB; Bapat B
    Oncol Rep; 2011 Mar; 25(3):809-15. PubMed ID: 21206982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
    Levine AJ; Phipps AI; Baron JA; Buchanan DD; Ahnen DJ; Cohen SA; Lindor NM; Newcomb PA; Rosty C; Haile RW; Laird PW; Weisenberger DJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):68-75. PubMed ID: 26512054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MLH1 -93 promoter variant influences gene expression.
    Mei M; Liu D; Dong S; Ingvarsson S; Goodfellow PJ; Chen H
    Cancer Epidemiol; 2010 Feb; 34(1):93-5. PubMed ID: 20060799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
    Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
    Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals.
    Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B
    PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
    Hubner RA; Houlston RS
    J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.